Abeona Therapeutics (ABEO) Shares Outstanding (Weighted Average) (2010 - 2026)

Abeona Therapeutics' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $56.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 13.75% year-over-year to $56.6 million; the TTM figure through Mar 2026 stood at $56.6 million (up 13.75% YoY), while the FY2025 annual figure was $53.0 million, up 29.0% from the prior year.
• Shares Outstanding (Weighted Average) was $56.6 million for Q1 2026 at Abeona Therapeutics, up from $5.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $18.0 billion in Q2 2023 to a low of $589681.0 in Q3 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $1.1 billion across 5 years, with a median of $7.9 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) jumped 1007611.07% in 2023, then slumped 99.78% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $7.9 million in 2022, then fell by 3.2% to $7.6 million in 2023, then surged by 439.41% to $41.0 million in 2024, then slumped by 85.96% to $5.8 million in 2025, then soared by 882.58% to $56.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $56.6 million (Q1 2026), $5.8 million (Q4 2025), and $52.2 million (Q3 2025), per Business Quant data.